SARS-CoV-2 Targeted Libraries for offer

Summary of the technology

Protease-Oriented SARS-CoV-2 Library (1017 Compounds) - Developed by Virtual Receptor-Based Screening Using the Crystal Structure of the Basic SARS-CoV-2 Protease (PDB ID: 6LU7)
ML (Machine Learning) SARS-target library (1577 compounds) - carefully developed using machine learning (artificial neural networks and Bayesian statistics).

Covid-19 Innovation Challenges by Innoget

Details of the Technology Offer

The Otava Research Institute cannot ignore today's challenges and presents targeted SARS-CoV-2 libraries that contain small compounds with putative SARS-CoV-2 activity http://bit.ly/38Y1TEI. We hope that these libraries will be useful for the study and development of drugs against # COVID19.

Protease-Oriented SARS-CoV-2 Library (1017 Compounds) - Developed by Virtual Receptor-Based Screening Using the Crystal Structure of the Basic SARS-CoV-2 Protease (PDB ID: 6LU7)
ML (Machine Learning) SARS-target library (1577 compounds) - carefully developed using machine learning (artificial neural networks and Bayesian statistics).

All warehouses are in stock, delivery is possible.

Be healthy and take care of yourself!

Related Keywords

  • Biological Sciences
  • Medicine, Human Health
  • Biostatistics, Epidemiology
  • Virus, Virology / Antibiotics / Bacteriology
  • Human vaccines
  • Emergency Medicine Technology
  • Infectious Diseases
  • Medical/health
  • Medical Health related
  • Other Medical/Health Related
  • Emergency medicine Market
  • Covid-19
  • compounds
  • sars-cov-2
  • compounds library
  • libraries

About Covid-19 Innovation Challenges by Innoget

Ahead of the current Coronavirus outbreak, Innoget is fully committed to contributing to mobilizing scientific and expert communities to find a real solution to the Covid-19 pandemic. Therefore, we're supporting worldwide calls and programs that could help in any aspects of the coronavirus crisis.

Is your organization promoting or looking for innovation or research initiatives to mitigate the Covid-19 outbreak? Email us at covid19@innoget.com to list them.

Channeled through Innoget's online open innovation network, initiatives in the health, virology, medicine, or novel technologies applied to human health, among others, are listed and disseminated to Innoget members -ranging from hospitals, research institutes, scientists, businesses, and public administrations- and innovation partners worldwide.

Covid-19 Innovation Challenges by Innoget

Never miss an update from Covid-19 Innovation Challenges by Innoget

Create your free account to connect with Covid-19 Innovation Challenges by Innoget and thousands of other innovative organizations and professionals worldwide

Covid-19 Innovation Challenges by Innoget

Send a request for information
to Covid-19 Innovation Challenges by Innoget

Submit your request

About Technology Offers

Technology Offers on Innoget are directly posted
and managed by its members as well as evaluation of requests for information. Innoget is the trusted open innovation and science network aimed at directly connect industry needs with professionals online.

Help

Need help requesting additional information or have questions regarding this Technology Offer?
Contact Innoget support